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Ile-Gly-Lys-Phe-Leu-His-Ser-Ala-Lys-Lys-Phe-Gly-Lys-Ala-Phe-ValGly-Glu-Ile-Met-Asn-Ser-NH,; PGLa, Gly-Met-Ala-Ser-Lys-Ala-GlyAla-ne-Ala-Gly-Lys-Ile-Ala-Lys-Val-Ala-~u-Lys-Ala-Leu-~~; P h 2 + , tetraphenylphosphonium ion. et al., 1992) . Like sarcotoxin-1 (Okada and Natori, 1985) , magainins interfere with membrane-mediated energy metabolism in Escherichia coli . Since this interference occurs at the same concentrations as the antimicrobial activity, we formulated the working hypothesis that membrane permeabilization followed by membrane-potential dissipation is the mechanism by which magainins kill their microbial targets .
In view of their tendency to form amphiphilic a-helices (Marion et al., 1988; Chen et al., 1988) , the approximately 23-residue, basic, magainins conform to prototypes of channelforming membrane peptides. Such channels would consist of complexes of peptide monomers (Guy and Raghunatan, 1988; Catterall, 1988; Kaiser and Kezdy, 1987; Lear et al., 1988; Vaz Gomes et al., 1993) . Alternatively, the peptides populate the membrane-solution interface (Bechinger et al., 1991) and compromise membrane stability (Williams et al., 1990; Cruciani et al., 1992; Grant et al., 1992) . Included in the magainin family are PGLa (Gly-Met-Ala-Ser-Lys-Ala-Gly-Ala-Ile-Ala-Gly-Lys Ile-Ala-Lys-Val-Ala-Leu-Lys-Ala-Leu-NH, ; Gibson et al., 1986 ; Giovannini et al., 1987) and magainin-2 (Gly-Ile-Gly-Lys-PheLeu-His-Ser-Ala-Ly s-Ly s-Phe -Gly -Lys -Ala-Phe-Val-Gly -GluIle-Met-Asn-Ser-NH,; Zasloff, 1987) . When studying the uncoupling activity of these peptides in rat liver mitochondria , protein-free liposomes (Vaz Gomes et al., 1993) and cytochrome oxidase liposomes (JuretiC et al., 1994) , we noted a higher than first-order dependence on peptide concentration. This reinforced the suggestion that a peptide oligomer was responsible for the uncoupling. The possibility that complexes of a number of magainin-2 molecules, or a number of PGLa molecules, are responsible for the action of these peptides, suggests that mixed complexes of magainin-2 and PGLa may also form (Williams et al., 1990) and disrupt membrane energization . In this interpretation, the results of this study show the heterocomplexes to be much more effective than their homocomplex counterparts in interfering with membrane-linked free-energy transduction and the viability of E. coli and certain human tumor cells.
MATERIALS AND METHODS

Materials.
Cytochrome oxidase (10-11 nmol heme d m g protein) was a gift from Dr W. Caughey. Asolectin was obtained from Fluka, purified as described by Darley-Usmar et al., 1987 , and stored under nitrogen at -70°C. The preparation of cytochrome oxidase liposomes followed the sodium cholate dialysis procedure (Hinkle et al., 1972; Wrigglesworth et al., 1987) . The phospholipid/protein ratio was 50 : 1 and the respiratory control ratio was 10 : 1 or higher. Egg phosphatidylcholine, dicetyl phosphate and the glucose oxidase/peroxidase kit for glucose determination were obtained from Sigma.
Magainin-2 and PGLa were the synthetic compounds with carboxyamidated C termini (Soravia et al., 1988) . Carbonylcyanide p-trifluoromethoxyphenylhydrazone (FCCP) and valinomycin were obtained from Fluka; tetraphenylphosphonium (Ph,P+) was from Aldrich.
Growth inhibition of E, coli. E. coli strain W3102 was grown overnight at 37°C with shaking in 0.5 X medium 56 (Monod et al., 1951) supplemented with 0.4% glucose or 1 pg/ml thiamine and 0.9% succinate. The culture was diluted and approximately 2X105 cells were plated in 2.5 ml molten 0.8% agar plates containing medium of the same composition. Subsequently, 10-pl samples of magainin were applied 2 cm apart and the plates were incubated for 2 days at 37°C.
Oxygen consumption by cytoehrome oxidase liposomes. The respiratory rate was measured with a Clark oxygen electrode in 1.8 ml50 mM potassium phosphate, pH 7.4, (JuretiC et al., 1994) . Background respiratory rates (liposomes absent) and coupled respiratory rates (in the absence of uncouplers or magainins) were also measured. Relative respiration rates were calculated as follows : the background oxygen consumption rate (JB) was measured at 25°C in the presence of 1.8 ml 50 mM potassium phosphate, pH 7.4, EDTA (0.56 mM), sodium ascorbate (5 mM), Nfl,N',N'-tetramethyl-p-phenylenediamine (83 pM), and cytochrome c (35 pM). The coupled respiratory rate (Jc) was recorded 3 min after cytochrome oxidase liposomes were added (0.14 mg/ml phospholipid in the oxygraph). The respiratory rate in the presence of peptide (Jp) was measured 1 min after the addition of each aliquot of peptide. The relative rate u, was calculated as (Jp-JB)/(Jc-JB). This preparation of cytochrome oxidase vesicles had a respiratory control ratio of 12.8 [measured after valinomycin (0.5 pM) and FCCP (0.6 pM) addition]. The enhancement in the respiratory rate caused by the peptides was calculated as uo = u, -1. uo is a normalized measure of the increase in respiratory rate caused by the peptide. The maximal uo (u,) value was estimated to be approximately 10% higher than the actually recorded maximum due to the inhibition of electron flow that occurred with higher peptide concentrations. The parameter Y = ud( ow-u,) was calculated for each titration point and plotted as log( r) versus log(peptide concentration). The peptide concentration corresponding to the Y value of 1 in the titration was divided by the lipid concentration in the oxygraph. The resulting activity parameter D,,, (pg peptide/mg phospholipid) was used to compare the capability of different peptides to cause half-maximal uncoupling of respiration rate in the presence of a known amount of liposomes.
EDTA treatment of E. coli. E. coli D31 cells grown in Luria-Bertani broth (10 g/l bacto-tryptone, 5 g/1 bacto-yeast extract, 5 g/l NaC1, pH 7.4) were harvested in the stationary phase, washed twice, and suspended in ice-cold 120mM Tris/HCl, pH 7.4. A 1-min incubation at 37°C in the same buffer was followed by 45 min incubation at 37°C in that buffer plus 1 mM EDTA. The incubation was ended by washing the cells in icecold 250 mM sucrose, 2 mM Hepes, 0.5 mM EDTA. pH 8 (medium D) . After resuspending the cells in the same medium, glycerol was added [to make a 10% (by vol.) mixture] and cells were stored as aliquots at -70°C.
Membrane-potential titrations. Ph,P+ was used as a probe for membrane potential developed upon energization of cytochrome oxidase vesicles or E. coli cells (Rottenberg, 1979) . The uptake of Ph,P+ was monitored by a macroscopic Ph,P+-ion selective electrode (modified from Hendler, 1991) in a stirred 25 "C reaction chamber that also contained an oxygen electrode and a glass pH electrode (Hendler, 1991) . All experiments were performed at 25°C with constant stirring. The aerobic state in the presence of excess substrate was maintained with mixtures of 0, and Ar blown over the surface of the suspension. In each experiment, the Ph,P+ electrode was calibrated by adding Ph,P+ in several aliquots until the final concentration was reached. Peptides added in the absence of energy-transducing membranes did not show any effect on the P g P + electrode. Cytochrome oxidase liposomes (0.7 mg/ml phospholipid) were added to 6.2 ml 50mM KC1, 1OmM Hepes, pH7.4, 0.6mM sodium EDTA, 85 pM N,N,N',N'-tetramethyl-p-phenylenediamine, 35 pM cytochrome c, 43 mM ascorbate, 21 mM potassium phosphate, and 20 pM Ph,P+. To maintain the aerobic state during the titrations, 0, was blown over the surface of the reaction mixture at a rate of 36 ml/min.
Binding of tritiated magainins to cytochrome oxidase liposomes. Tritiated magainin-2 (labelled at Glyl) was diluted 25 times in 2 mg/ml unlabelled magainin-2. 8 p1 sample gave an average of 33000 dpm (ACS scintillation cocktail). 1-ml plastic centrifuge tubes were used. Each tube had 500 pl 50 mM potassium phosphate, pH 7.4, cytochrome oxidase vesicles at the indicated amount (mg dry mass phospholipid) and peptides. The respiratory control ratio was low in this preparation (7.7 after valinomycin and FCCP addition). This solution was mixed with 8 pl peptide stock (to give approximately 30000 dpm) on a vortex mixer, and centrifuged at 100000 rpm (Beckman TL-loo), for 10 min at 15°C. The supernatant was decanted (the pellet was very tight) directly into the scintillation vial. The pellet was carefully mixed with a thin glass rod in the presence of 250 pl 1.7% SDS. The solution was stirred on the vortex mixer, decanted into the scintillation vial, and the entire operation was repeated with another 250 pl SDS.
Glucose eMux from liposomes. Liposomes of egg phosphatidylcholine and dicetyl phosphate in a molar ratio of 9 : 1, were prepared by the extrusion method as described in MacDonald et al. (1991) . The lipid mixture was vacuum dried and hydrated with 10 mM Hepes, 50 mM glucose, pH 7.0, to a final lipid concentration in the suspension of 10 mg/ml. After freeze-thawing five times (Mayer et al., 1985) , the lipid suspension was extruded five times through Nucleopore filters of 400-nm pore diameter, followed by another series of five extrusion steps through Nucleopore filters of 200-nm diameter. The Liposofast system was used as an extruding device. Before the glucose efflux assays were performed, the external medium was replaced by 10 mM Hepes, 25 mM NaCl, pH 7.0, by column centrifugation through Sephadex G-50 (Penefsky, 1977) .
The efflux of glucose was monitored spectrophotometrically using the glucose oxidasetperoxidase assay. In this assay, the formation of reduced o-dianisidine is monitored at 450 nm. We have used the assay conditions suggested by Sigma, except the concentration of the glucose-oxidase/peroxidase enzymes was twofold higher, to allow for continuous monitoring at room temperature (approximately 25 "C). The reference cuvette contained 100 pl 10 mM Hepes, 25 mM NaC1, pH 7.0, and 1 ml combined reagent (glucose-oxidaselperoxidase enzymes and oxidised o-dianisidine). The control for intrinsic glucose leakage of the liposome population contained 90 pl buffer and 10 pl lipid suspension (90 pg/ml final lipid concentration), plus the combined reagent (1 ml). To study the membrane permeability induced by the different magainin peptides, the appropriate volume of peptide solution was added, subtracting accordingly the volume of buffer added. Monitoring started immediately after mixing the assay mixture by inversion five times. The initial rates were linear up to a concentration of 5 pM glucose, and the response was immediate when an external standard of glucose (1.27 pM) was added to an assay mixture containing liposomes and peptides.
Clonogenicity assay of mammalian cells. The human melanoma cell line BRO (Lockshin et al., 1985 ; for possible contamination with retrovirus-like activity see Schinkel et al., 1993) was cultured on HAM F10 medium (no. 074-1200, Gibco), supplemented with 10% fetal bovine serum and antibiotics in a humidified atmosphere supplied with 5% CO, at 37°C. The synergism between magainin-2 and PGLa was determined from doseresponse curves using a slightly modified clonogenicity assay. Exponentially growing cells were treated with trypsin and transferred to wells of Terasaki microtest plates (3034F; Falcon) resulting in approximately 300 cells for each 30 pl growth medium containing various concentrations of magainin-2, PGLa, or a mixture of these drugs. After incubation for 75 min (the microtest plate was incubated upside down to avoid anchorage), the cells were transferred again and plated in wells of a tissue-culture cluster (no. 3424; Costar, Cambridge, MA) to grow for 10 days in normal medium. After fixation and staining with 0.2% crystal violet (Merck 820603) in 3.7% glutaraldehyde, colonies of at least 100 cells were counted. The amount of surviving cells was determined as the number of such colonies grown from treated cells relative to those grown from untreated cells. From the dose-response curves, the D,, values were obtained representing the concentration of magainin peptides that allow 10% of the cells to form a colony after a 75-min treatment.
RESULTS
Synergism between PGLa and magainin-2 in inhibiting bacterial growth. The magainins were discovered on the basis of their antimicrobial activity (Zasloff, 1987) . To determine if the combination of magainin-2 and PGLa has additional activity when compared to either of the peptides alone, we measured the ability of E. coli strain W3102 to grow in the presence of these peptides. W3102 was grown overnight at 37°C in minimal medium and was plated in top agar of the same medium. 10-p1 samples of magainin-2 or PGLa were spotted onto the surface of the plate and the plates were incubated at 37°C. For each peptide, a circular zone (diameter approximately 2 cm) appeared where the peptides diffused through the top agar and prevented the growth of the cells (Fig. 1 A) . In the regions where magainin-2 and PGLa could interact with each other (Fig. 1 A) , additional inhibition was observed. No such zone of growth inhibition appeared at the junction of two spots of the same peptide (Fig. 1 B) . This demonstrates a synergistic antimicrobial effect of PGLa and magainin-2. Synergistic action of PGLa and magainin-2 against tumor cells. Magainins have also been shown to compromise the viability of mammalian tumor cells (Cruciani et al., 1991 ; Baker et al., 1993) . Combinations of magainin peptides have not been investigated by these authors for the presence of synergism. To examine whether PGLa and magainin-:! are also synergistic for tumor cells, we incubated cells of a human melanoma cell line for 75 min in the presence of either peptide, or of a mixture of the two and determined their clonogenicity. As judged after 10 min by microscopic inspection of the exclusion of Hoechst 33258, the synergistic combination of the peptides was more active than the individual compounds (data not shown).
In terms of the effect on proliferation capacity of the tumor cells, the synergism was even higher. Whereas 0.65 mg/ml magainin-2 and 1.0 mg/ml PGLa were required to reduce the number of colonies observed 10 days after plating of the cells to lo%, ten times less of the 1 : 1 mixture was sufficient to produce the same effect (Fig. 2) . The synergism of the 1 : 1 mixture was much higher than that of the 1 : 5 mixtures.
Synergistic membrane-potential dissipation in E. coli. To examine at which level of complexicity the two peptides act syner- gistically, we also determined the combined activity in the processes presumed to be responsible for magainin action. We showed previously that PGLa or magainin-2 alone can dissipate the membrane potential in E. coli ). Again we used Ph,P+ uptake, now to probe for synergistic effects on this membrane potential. The initial upward shift in Fig. 3 corresponds to a decrease in the Ph,P+ concentration due to binding to the cells and to the equilibration of the medium with the cytoplasm, which has a negative electric potential with respect to the outside of the cells. Addition of succinate produced a further decrease in the external Ph,P+ concentration, because of the increase in the apparent membrane potential. Addition of dicyclohexyl carbodiimide [cHxN),C] appeared to decrease the membrane potential slightly. The onset of anaerobiosis decreased the membrane potential further. At the end of the titration with peptides, valinomycin and nigericin were added to ensure the complete dissipation of the membrane potential. The effect of the first addition of magainin-2 alone on the membrane potential of E. coli (Fig. 3) was quickly reversed, most probably due to proteolytic cleavage of magainin-2 (JuretiC et al., 1989a) . The same amount of magainin-2 added after a much smaller amount of PGLa had been added (Fig. 3) caused a profound membrane-potential decrease, also suggesting a significant synergism between PGLa and magainin-2 in this action. Changes in the reading of the Ph,P+ ion-selective electrode can be converted into apparent membrane potential changes (Hendler et al., 1983) . We estimated (data not shown) that the second addition of magainin-2, in the magainin-2 titration (Fig. 3) , caused a 10% decrease in the apparent membrane potential. The first addition of magainin-2 in the mixed titration, i.e. after PGLa, caused a 25% decrease in the apparent membrane potential. Magainin-2 enhances the uncoupling and depolarizing activities of PGLa in cytochrome oxidase liposomes. The membrane potential of intact E. coli cells is a complex function of the activity of a multitude of processes. To probe for the basis of the synergistic effect, we directed our attention to a model system for studying the interference of magainins with membrane-mediated free-energy transduction, namely cytochrome oxidase liposomes (JuretiC et al., 1989a (JuretiC et al., , 1994 . Cytochrome oxidase vesicles develop a membrane potential in the presence of ascorbate, N,N,N',N'-tetramethyl-p-phenylenediamine and cytochrome c. In Fig. 4 , we show the effects of magainin-2 and PGLa, added separately, and in combination, on the apparent membrane potential. In the presence of 20 nmol magainin-2, 5 nmol PGLa (0.7 pM in the reaction chamber) caused a quick and pronounced decrease in the membrane potential. In the absence of magainin-2, the kinetics of the membrane-potential change provoked by PGLa were slower and the extent was less pronounced.
Since the rate of oxygen consumption in well-coupled cytochrome oxidase liposomes is strongly inhibited by membrane potential, the stimulation of that respiration rate by magainin is expected. Indeed, magainin-2 and PGLa increased the rate of oxygen consumption (Fig. 5) . That synergism exists between PGLa and magainin-2 is also evident from Fig. 5 A. In the presence of a small amount (4.4 yg/ml) of magainin-2, PGLa was approximately ten times more effective than in the absence of magainin-2.
The sigmoidal character of the curves, which is indicative of cooperativity between peptide monomers, can be quantified as a cooperativity parameter (JuretiC et al., 1994; Vaz Gomes et al., 1993) , which is in this case (Fig. 5B) 4.3 for magainin-2, 2.5 for PGLa, and 1.7 for PGLa titration after magainin-2 addition. D,, was defined as the peptide to phospholipid ratio (by mass) causing half-maximal uncoupling of respiration. From the results presented in Fig. 5, D,, , decreased from 99 yg/mg for the titration of respiratory rate with magainin-2 alone to 39 yglmg for the titration with PGLa alone, and to 4 yg/mg when a small amount of magainin-2 was present during titration with PGLa. Additional evidence for the synergism between these two peptides is presented in Table 1 . The peptides were most active in uncoupling the respiration when their ratio was 1 : 1 (by mass).
Synergistic increase in glucose permeability. Magainins have been shown to increase the permeability of membranes in a nonselective manner (Duclohier et al., 1989; Westerhoff et al., 1989a; Matsuzaki et al., 1990; Grant et al., 1992 ; Vaz Gomes 10 mn. Time (min) Fig. 7 . In the presence of liposomes, PGLa protects magaini-2 from pronase action. In the lower trace, pronase can reverse the uncoupling of respiration caused by magainin-2 (11 pM). After sodium EDTA, sodium ascorbate, N,N,N',N'-tetramethyl-p-phenylenediamine, cytochrome c, and pronase (Pr; 0.056 mg/ml), magainin-2 (M; 11 pM) was introduced 2 min before the addition of the oxidase liposomes (L; 0.17 mgl ml), and again, as indicated. Valinomycin (V; 0.56 pM) and FCCP (F; 0.56 pM) were added when indicated. In the upper trace, PGLa prevents the reversal by pronase. The second magainin-2 addition (11 pM), added 2 min after PCLa (P; 1.4 pM), produced a constant uncoupled respiration rate, that did not change significantly even after two additional ahquots (0.056 mg/ml) of pronase, and the usual amounts of valinomycin and FCCP, were added (data not shown). , 1993) . To examine if the synergism extended to include this non-selective action we determined the effects of magainin-2, PGLa and their combination on the efflux of glucose from protein-free liposomes. The magainin-induced (8 pg/ml) efflux of glucose out of egg phosphatidylcholine/dicetyl phosphate (9 : 1 molar ratio) large unilamellar liposomes is shown in Fig. 6 . When no magainin peptides were added, this liposomal preparation showed an intrinsic glucose efflux of 0.15 arbitrary absorbance units/min (one absorbance unit corresponds to A,,, 0.01). The initial rates of glucose efflux, measured for magainin-2, PGLa and the mixture (1 : 1) of the two peptides at the same total concentration, were 0.21, 0.35 and 0.90 absorbance unitdmin, respectively. The synergism between magainin-2 and PGLa is revealed by these values. After 45 min, the extent of glucose leakage for magainin-2, PGLa or the mixture was steady and amounted to 19, 25 and 28 absorbance units, respectively. Apparently, the synergism between the two peptides is more pronounced in terms of the rate of permeabilization than in terms of the extent of permeabilization of the liposomes.
PGLa protects magainin-2 from pronase inactivation in the presence of cytochrome oxidase liposomes. The increased effectiveness of magainin-2 in dissipating the membrane potential and inhibiting bacterial growth in the presence of PGLa, could be due to a decreased rate of magainin-2 degradation in the presence of PGLa, and/or to an enhanced permeabilizing activity of a presumed PGLdmagainin-2 complex. Our experiments with the reconstituted system suggest that the second explanation is valid, but we wanted to investigate whether PGLa can also protect magainin-2 from hydrolytic degradation in the presence of the lipid phase.
The uncoupling of respiration, which can be measured as an increase in the relative respiration rate (Fig. 5 A) or as a decrease in the respiratory control ratio, is a convenient assay for measuring the activity of small concentrations of magainins (JuretiC et al., 1989a (JuretiC et al., , 1994 . In Fig. 7 , magainin-2 alone and magainin-2 added after a small amount of PGLa are compared with respect to their uncoupling activity in the presence of the proteolytic enzyme pronase. In Fig. 7 , magainin-2 was added in an amount (11 pM, i.e. 27 pg/ml) sufficient to produce the fully uncoupled respiratory rate, provided liposomes were already present (compare the second addition to first addition in the lower trace; see also JuretiC et al., 1994 and Fig. 5A ). However, in the absence of PGLa the inactivation of magainin-2 by the previously added pronase, quickly returned this rate to the level of coupled respiration. Subsequent valinomycin and FCCP addition were still capable of increasing the respiratory rate to the maximal level for this preparation in the absence of pronase. This maximal level was the same as that reached if magainin-2 was added alone (data not shown).
When a small amount of PGLa had been added prior to the addition of magainin-2 (the upper trace in Fig. 7) , the increase in rate persisted, indicating that in this case, magainin-2 was protected from pronase activity. The addition of valinomycin and FCCP (data not shown) did not change the respiratory rate reached after PGLa and magainin-2 addition. It should be noted in Fig. 7 that the synergistic protection of magainin against pronase depended on the presence of liposomes at the moment of addition of the peptides.
Binding of tritiated magainin-2 is enhanced by the presence of PGLa. Protection of magainin-2 from pronase action could be due to the formation of an aqueous complex between the two peptides that is more resistant against pronase digestion. Since the protection depends on the presence of liposomes however (Fig. 7) , this possibility is unlikely. Rather, PGLa addition may enhance the binding of magainin-2 to the lipid phase where it is inaccessible to pronase action (JuretiC et al., 1989a) . Table 2 shows that magainin-2 bound to cytochrome-oxidase-containing liposomes, when the latter were presented at 5 mg phospholipid/ml. Added unlabelled PGLa enhanced the binding of magainin-2. This suggests that at least part of the functional synergism results from an increased affinity of the presumed PGLdmagainin-2 complex, to membranes.
It may be noted that at a concentration of phospholipids of almost three times that used in Fig. 7 (0.17 mg/ml), only a fraction of magainin-2 was pelleted when centrifuged, even in the presence of excess PGLa. When the liposome concentration was increased tenfold, only one third of magainin-2 was pelleted by centrifugation. Our liposomal preparation is probably hetero-geneous and magainin-2 also binds to liposomes (e.g. those that lack cytochrome oxidase) that are lighter than the medium.
DISCUSSION
The antimicrobial activity of the secretion of the granular gland of X . laevis is not only due to magainin-1 and magainin-2 (Zasloff, 1987) , but is also due to other small cationic peptides such as PGLa and xenopsin precursor fragment, XPF (Soravia et al., 1988) . These peptides uncouple free-energy transduction in bacteria, mitochondria and cytochrome-c oxidase vesicles most probably by permeabilizing the membranes to small ions (Westerhoff et al., 1989a,b; JuretiC et al., 1989a JuretiC et al., , 1994 Duclohier et al., 1989; Cruciani et al., 1991 ; Vaz Gomes et al., 1993) . In this study, we report that in the case of magainin-2 and PGLa the combination of these two peptides has a much stronger activity than either peptide alone. The synergism in membrane depolarization was also observed between magainin-1 (non-amidated) and PGLa (data not shown).
The key aspect of the present study is that the peptides act synergistically in their biological activities. First, strong synergism appears where the peptides are supposed to function; i.e. in antimicrobial action. Secondly, this functional synergism extends to cytotoxicity for other cell types, including tumor cells where magainins may have a pharmaceutical future (Cruciani et al., 1991; Baker et al., 1993; compare De Waal et al., 1991) . In addition, we showed that the synergism occurs at the mechanistic level, i.e. with respect to their biochemical and biophysical activities in vitro. The combination of magainin-2 and PGLa stimulated respiration in cytochrome oxidase liposomes more than either peptide alone (compare JuretiC et al., 1989b) . Moreover, glucose permeability of protein-free liposomes was induced synergistically. The latter result is in agreement with studies with the artificial permeability probes carboxyfluorescein and calcein (Williams et al., 1990; Vaz Gomes et al., 1993) .
The present study focuses on the occurrence of synergism between PGLa and magainin-2. This should not obscure the fact that synergism is a special rather than a common phenomenon with membrane-active peptides. Various magainin peptide combinations do not exhibit synergism. Indeed PGLa in combination with any of a set of magainin-2 analogues is particularly active in terms of synergism (compare De Waal et al., 1991; Vaz Gomes et al., 1993) . This phenomenon may identify not only a biological function of these two naturally occurring peptides, but also may provide information with respect to the structural requirements for the proposed membrane-active peptide complex.
Although additional effects of magainins should not be excluded, their membrane permeabilization and depolarization and consequent interference with membrane-mediated free-energy transduction is a well-documented chain of events that can account for their cytotoxicity. Additional or even alternative mechanisms for the cytotoxic action cannot be excluded however. It is now pertinent to ask what extent the observation of synergism between magainin-2 and PGLa will provide information on the mechanism of cytotoxic action of the magainin peptides. First, the fact that the synergism between the two peptides was observed in all experimental systems, from the liposomal permeation of neutral molecules to anti-tumor cell activity, is in agreement with the concept that the permeabilization is responsible for the cytotoxicity. Indeed, it is quite feasible that the combination of the two peptides has increased membrane-permeabilizing activity due to the enhanced formation of a membraneactive complex, or to a higher intrinsic permeability of a membrane-active complex consisting of both peptides.
Secondly, that the active magainin form is a complex of magainin peptides (possibly including .lipids) rather than a monomer, was suggested on the basis of the higher than first-order concentration dependence of the uncoupling of respiration in mitochondria and cytochrome oxidase liposomes (Westerhoff et al., 1989a; JuretiC et al., 1994) and the permeabilization of protein-free liposomes (Vaz Gomes et al., 1993) . Due to the lack of assays that are a linear function of peptide concentration, it has been more difficult to demonstrate (homo)cooperativity in terms of biological function. The synergism shown in Figs 1 and 2 demonstrates that the effect on biological function of the formation of a magainin multimer may also be relevant.
Thirdly, our experiments with a simple reconstituted system, cytochrome-c oxidase vesicles, demonstrated that (a) the presence of a membrane phase retards the inactivation of these peptides by added proteolytic enzyme, and (b) a mixture of PGLa and magainin-2 is less sensitive to protease than magainin-2 alone. This observation is most easily understood in terms of enhanced binding of a PGLdmagainin-2 heterocomplex as compared to a magainin-2/magainin-2 homocomplex to the phospholipid membrane, where both peptides are better protected from pronase hydrolytic cleavage. Accordingly, the binding of tritiated magainin-2 to liposomes was enhanced in the presence of PGLa (Table 2) .
A fourth and quite crucial conclusion stems from our observation that the uncoupling action of a PGLa and magainin-2 mixture was reversed by pronase (with suitably chosen peptide concentrations), i.e. magainin action is not a lytic event of irreversible nature.
In view of the functional activity of possible heterocomplexes, the finding of mRNA (actually cDNA) molecules that each contain the information for a large prepro-polypeptide comprising a number of magainin molecules (Zasloff, 1987; Terry et al., 1988; compare Hunt and Barker, 1988 ) may be relevant; the different magainin species encoded by a single mRNA might function synergistically. However, at least in one case, the mRNA encoded one complete magainin-1 and five complete magainin-2 sequences (Terry et al., 1988) , whereas these two magainins do not synergize much (De Waal et al., 1991) .
With respect to these possibilities, the results of the present study suggest that complexation of different transmembrane peptides greatly enhances their membrane permeabilization effect as compared to the complexation of identical peptides. As for X . Zaevis itself, the putative PGLdmagainin-2 complex may be the antimicrobial binary weapon of choice in the frog; either of the peptides alone may be relatively harmless to both target and host, but in response to infection, Xenopus may solicit the combination of the two peptides so as to produce the more active peptide mixture only when and where it is needed. PGLa and magainin-2 immune reactivity have been detected in single granules (Moore et al., 1992) . The toxic synergistic combinations may arise only after processing of the prepro-polypeptides.
The in vivo synergistic action may therefore be the biological reason for the diversity of antimicrobial peptides found in the granular gland secretions. There is no compelling reason to suspect that synergism between magainins is confined to the combination of PGLa and magainin-2. Indeed, there is the possibility that the putative most active antimicrobial complex consists of six different magainins. Such a heterocomplex could be superior to the presumed homocomplexes by an increased tendency to adsorb onto or into the target membrane, providing the advantages of being less accessible to aqueous proteases and closer to the site of action.
A different type of synergistic combination was shown by Darveau et al. (1991) , when the simultaneous action of magainin-2 and P-lactamic antibiotics was studied in E. coli. This type
